Dr. Jeanette Hill manages in vitro services for CellzDirect including contracted drug metabolism projects for in vitro CYP450 induction studies, in vitro cytochrome P450 inhibition (drug-drug interaction) studies, metabolite profiling, and enzyme identification studies. Dr. Hill began her career as an analytical chemist at Sigma Chemical Company. She received her doctorate from Washington University and completed post-doctoral research in autoimmune diabetes at Case Western Reserve University where she studied the inflammatory processes involved in alcoholic liver disease, focusing on the role of Kupffer cells, cytokine release, nitric oxide and apoptotic signaling on hepatocyte destruction and liver damage. As a senior scientist/manager at Ricerca Biosciences, LLC, Dr. Hill directed an In Vitro Drug Screening/DMPK group for performance of contracted drug development and discovery studies. Her additional duties included scientific consultation, business development and proposal preparation. |